Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
23 auth. I. Heidegger, G. Fotakis, A. Offermann, J. Goveia, S. Daum, S. Salcher, A. Noureen, H. Timmer‐Bosscha, G. Schäfer, A. Walenkamp, ... S. Perner, Aleksandar Beatovic, M. Moisse, C. Plattner, A. Krogsdam, J. Haybaeck, S. Sopper, Stefanie Thaler, M. Keller, H. Klocker, Z. Trajanoski, D. Wolf, A. Pircher